Adenocarcinoma of the Colon Clinical Trials

5 recruiting

Adenocarcinoma of the Colon Trials at a Glance

8 actively recruiting trials for adenocarcinoma of the colon are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in New York, Indianapolis, and Boston. Lead sponsors running adenocarcinoma of the colon studies include GV20 Therapeutics, Jun Huang, and Case Comprehensive Cancer Center.

Browse adenocarcinoma of the colon trials by phase

Treatments under study

About Adenocarcinoma of the Colon Clinical Trials

Looking for clinical trials for Adenocarcinoma of the Colon? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adenocarcinoma of the Colon trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adenocarcinoma of the Colon clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Adenocarcinoma of the Colon
University College, London88 enrolled6 locationsNCT05197322
Recruiting

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

Adenocarcinoma of the RectumStage III Colorectal CancerAdenocarcinoma of the Colon+2 more
Case Comprehensive Cancer Center50 enrolled1 locationNCT04624555
Recruiting
Not Applicable

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the RectumAdenocarcinoma of the Colon
NRG Oncology9,500 enrolled480 locationsNCT05080673
Recruiting

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Colon CancerLiver Metastasis Colon CancerAdenocarcinoma of the Rectum+2 more
Memorial Sloan Kettering Cancer Center80 enrolled1 locationNCT04668872
Recruiting
Phase 3

mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang166 enrolled1 locationNCT06791512
Recruiting
Phase 1Phase 2

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+2 more
GV20 Therapeutics350 enrolled3 locationsNCT07070518
Recruiting
Not Applicable

Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery

Adenocarcinoma of the Colon
Yonsei University304 enrolled1 locationNCT07129512
Recruiting
Phase 1Phase 2

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Solid Tumor, AdultCutaneous MelanomaRefractory Cancer+3 more
GV20 Therapeutics365 enrolled13 locationsNCT05669430